tirzepatide program Can Help You Lose Weight? VivioMD GLP-1 Program Overview 2026:

Eligibility criteria typically include a BMI of 30 or above, or 27 or above with a weight-related health condition

However, additional evidence directly comparing pulmonary aspiration rates between a 24-hour clear liquid diet and the standard 8-hour fasting period, especially in patients with diabetes and obesity, is needed before this strategy can be widely implemented for those on GLP-1 agonists

We are located in Franklin, Milwaukee, Menomonee Falls, and Waukesha, Wisconsin

Tirzepatide is an approved drug for the treatment of type 2 diabetes and is probably useful to treat obesity (vide supra)

Barengolts, E., Green, S